[1] 潘中允.临床核医学[M].北京:原子能出版社,1994.409-11. [2] 马寄晓,朱瑞森,罗全勇,等.131Ⅰ治疗甲状腺功能亢进征远期观察[J].中华核医学杂志(Chin JNuclMed),1984,4(1):7-11. [3] 何国荣,龙国进.不同标准源放置方法测定甲状腺摄131Ⅰ功能的比较[J].第一军医大学学报,2002,22(3):259-61.He GR, Long GJ. Replacement of neck phantom with a stand for irradiation source support in thyroid radioiodine uptake test [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(3): 259-61. [4] 周永立,田碧文.老年性甲状腺功能亢进性心脏病31例临床分析[J].第一军医大学学报,2002,22(5):447.Zhou YL, Tian BW. Clinical analysis of hyperthyroid heart disease in 31 elderly patients[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(5): 447. [5] 潘明志,管昌田.131Ⅰ治疗重度甲状腺肿大伴甲状腺功能亢进[J].华西医学,1995,10(3):329-30.Pan MZ, Guan CT. 131Ⅰ therapy of serious goiter with hyperthyroidism [J]. West Chin Med, 1995, 10(3): 329-30. [6] Imesis RE, Vanmiddlesworth L, Massie JD, et al. Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine- 131 in hyperthyroidism [J]. J Clin Endocrinol Metab,1998, 83(2): 685-7. [7] Alexander EK, Larsen PR. High dose 131Ⅰ therapy for the treatment of hyperthyroidism caused by Graves’ disease [J]. J Clin Endocrinol Metab, 2002, 87(9): 1073-7. [8] Franklyn JA, Maisonneuve P, Sheppard MC, et al. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study [J]. Lancet, 1999, 353(143): 2111-5. |